Exogenous IL-33 restored tumor-residing dendritic cell (DC) activation and maturation via direct ST2-mediated signaling and induced antitumor T-cell responses in a syngeneic tumor model and pulmonary adenocarcinoma [44, 45]. This evidence concerns the gene IL1RL1 and neoplasm.